NOBEL BIOCARE USA, LLC
Manufacturer adverse-event records for NOBEL BIOCARE USA, LLC come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.
FDA MAUDE device safety record · 2005–2026 · mid-book · quiet Death-code · injury-heavy
Injury-mix signature
NOBEL BIOCARE USA, LLC leans injury-heavy in event_type mix
Injury-coded event_type share is 99.8% (injury-heavy tercile) beside 0.00% Death-coded (quiet). Volume band: mid.
What the Injury-mix reading shows for NOBEL BIOCARE USA, LLC
The standout signal for NOBEL BIOCARE USA, LLC is Injury-mix: 99.8% Injury-coded (injury-heavy) beside 0.00% Death-coded, on a mid-book footprint.
Mid-pack volume still shows a clear device fingerprint; the table below is the actionable layer for NOBEL BIOCARE USA, LLC. Event_type Death/Injury codes differ from patient-outcome rows - see methodology.
Reports span 4 device types, led in this extract by Injury at 20,036 (99.8% of event_type total). Peak single-year volume reaches 12,661 reports across 15 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.
Event Types
Patient Outcomes
FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.
Devices (4)
| Device | Reports |
|---|---|
| Implant, Endosseous, Root-Form | 20,049 |
| Abutment, Implant, Dental, Endosseous | 18 |
| Accessories, Implant, Dental, Endosseous | 1 |
| Screwdriver | 1 |
Yearly Trend
Read our methodology - how this data is sourced, computed, and verified.